154 related articles for article (PubMed ID: 18204809)
1. A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation.
Liguori M; La Russa A; Manna I; Andreoli V; Caracciolo M; Spadafora P; Cittadella R; Quattrone A
J Neurol; 2008 Jan; 255(1):127-9. PubMed ID: 18204809
[No Abstract] [Full Text] [Related]
2. Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy.
Verny C; Loiseau D; Scherer C; Lejeune P; Chevrollier A; Gueguen N; Guillet V; Dubas F; Reynier P; Amati-Bonneau P; Bonneau D
Neurology; 2008 Mar; 70(13 Pt 2):1152-3. PubMed ID: 18287570
[No Abstract] [Full Text] [Related]
3. Hereditary optic neuropathies share a common mitochondrial coupling defect.
Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
[TBL] [Abstract][Full Text] [Related]
4. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1.
Payne M; Yang Z; Katz BJ; Warner JE; Weight CJ; Zhao Y; Pearson ED; Treft RL; Hillman T; Kennedy RJ; Meire FM; Zhang K
Am J Ophthalmol; 2004 Nov; 138(5):749-55. PubMed ID: 15531309
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
[TBL] [Abstract][Full Text] [Related]
6. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.
Amati-Bonneau P; Guichet A; Olichon A; Chevrollier A; Viala F; Miot S; Ayuso C; Odent S; Arrouet C; Verny C; Calmels MN; Simard G; Belenguer P; Wang J; Puel JL; Hamel C; Malthièry Y; Bonneau D; Lenaers G; Reynier P
Ann Neurol; 2005 Dec; 58(6):958-63. PubMed ID: 16240368
[TBL] [Abstract][Full Text] [Related]
7. Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data.
Ferré M; Caignard A; Milea D; Leruez S; Cassereau J; Chevrollier A; Amati-Bonneau P; Verny C; Bonneau D; Procaccio V; Reynier P
Hum Mutat; 2015 Jan; 36(1):20-5. PubMed ID: 25243597
[TBL] [Abstract][Full Text] [Related]
8. Neuroradiological findings expand the phenotype of OPA1-related mitochondrial dysfunction.
Roubertie A; Leboucq N; Picot MC; Nogue E; Brunel H; Le Bars E; Manes G; Angebault Prouteau C; Blanchet C; Mondain M; Chevassus H; Amati-Bonneau P; Sarzi E; Pagès M; Villain M; Meunier I; Lenaers G; Hamel CP
J Neurol Sci; 2015 Feb; 349(1-2):154-60. PubMed ID: 25641387
[TBL] [Abstract][Full Text] [Related]
9. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier.
Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M
Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096
[TBL] [Abstract][Full Text] [Related]
10. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.
Sarzi E; Angebault C; Seveno M; Gueguen N; Chaix B; Bielicki G; Boddaert N; Mausset-Bonnefont AL; Cazevieille C; Rigau V; Renou JP; Wang J; Delettre C; Brabet P; Puel JL; Hamel CP; Reynier P; Lenaers G
Brain; 2012 Dec; 135(Pt 12):3599-613. PubMed ID: 23250881
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.
Ham M; Han J; Osann K; Smith M; Kimonis V
Mitochondrion; 2019 May; 46():262-269. PubMed ID: 30165240
[TBL] [Abstract][Full Text] [Related]
12. Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.
Lee J; Jung SC; Hong YB; Yoo JH; Koo H; Lee JH; Hong HD; Kim SB; Chung KW; Choi BO
Mol Med Rep; 2016 Jul; 14(1):33-40. PubMed ID: 27150940
[TBL] [Abstract][Full Text] [Related]
13. First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation.
Kamakari S; Koutsodontis G; Tsilimbaris M; Fitsios A; Chrousos G
Mol Vis; 2014; 20():691-703. PubMed ID: 24883014
[TBL] [Abstract][Full Text] [Related]
14. Optic atrophy and sensorineural hearing loss in a family caused by an R445H OPA1 mutation.
Li C; Kosmorsky G; Zhang K; Katz BJ; Ge J; Traboulsi EI
Am J Med Genet A; 2005 Oct; 138A(3):208-11. PubMed ID: 16158427
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
[TBL] [Abstract][Full Text] [Related]
16. A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.
Ahmad KE; Davis RL; Sue CM
J Neurol; 2015 Oct; 262(10):2323-8. PubMed ID: 26194196
[TBL] [Abstract][Full Text] [Related]
17. Optic mitochondriopathies.
Chinnery PF; Griffiths PG
Neurology; 2005 Mar; 64(6):940-1. PubMed ID: 15781804
[No Abstract] [Full Text] [Related]
18. The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene.
Amati-Bonneau P; Odent S; Derrien C; Pasquier L; Malthiéry Y; Reynier P; Bonneau D
Am J Ophthalmol; 2003 Dec; 136(6):1170-1. PubMed ID: 14644237
[TBL] [Abstract][Full Text] [Related]
19. Intrafamilial "DOA-plus" phenotype variability related to different OMI/HTRA2 expression.
Napolitano F; Terracciano C; Bruno G; Nesti C; Barillari MR; Barillari U; Santorelli FM; Melone MAB; Esposito T; Sampaolo S
Am J Med Genet A; 2020 Jan; 182(1):176-182. PubMed ID: 31609081
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation (LEU396ARG) in OPA1 is associated with a severe phenotype in a large dominant optic atrophy pedigree.
Schnieders MJ; Goar W; Griess M; Roos BR; Scheetz TE; Stone EM; Fingert JH
Eye (Lond); 2018 Apr; 32(4):843-845. PubMed ID: 29350691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
